A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2018 - Taylor & Francis
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2017 - europepmc.org
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi… - Human vaccines & …, 2018 - pubmed.ncbi.nlm.nih.gov
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2018 - ingentaconnect.com
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
[HTML][HTML] A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2018 - ncbi.nlm.nih.gov
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2017 - europepmc.org
Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …
This randomized, controlled, observer-blind phase I study and extension study in Belgium …